Introduction 5-HT 3 receptor antagonists. In France, approval of 5-HT 3 receptor antagonists is not restricted with regard to the Guidelines for clinical practice are being promoted as a way of helping practitioners to reach clinical decisions, indications for use, which are defined as the 'preventive and curative treatment of chemotherapy-induced nausea and of improving the effectiveness and reducing unnecessary costs of health care. However, despite increasing and vomiting'. In January 1995, the oncologists decided to standardize enthusiasm for such guidelines, there is limited evidence that they have any lasting impact on clinical practice. the antiemetic regimens prescribed in the Tenon Hospital. Radiotherapists and respiratoy physicians were also Their success depends on several factors, including the methods of their elaboration, dissemination and prescribers of chemotherapy in our hospital, and together with the oncologists, constituted a Working Group. implementation. Once the guidelines have been worked out and implemented, the question is to ascertain whether These senior clinicians agreed to approve recommendations based on the opinions of a panel of outside or not they are having the impact expected. It is therefore important to carry out studies to determine whether the experts, according to the Delphi technique, and to participate in an antiemetic utilization study, to be guidelines actually reach the physicians for whom they are intended.
conducted both before and after the implementation of guidelines for this purpose. In 1994, the most costly drugs in the pharmacy of our
The aim of this study was to describe the way in which the following objectives can be achieved: the
Implementation of the experts' recommendations Methods

The process developed by the Tenon Working Group
During the 4th quarter of 1996, a specific course of training for clinicians was started. In accordance with the included three stages: the drafting of guidelines based on experts' recommendations resulting from the Delphi previously published guidelines for medical practice [5] [6] [7] an antiemetic prescription order form, which summarized Technique, implementation of the guidelines, and assessment of their impact.
the guidelines (Appendix 1), had to be used at the time of prescription and sent to the hospital pharmacy. After October 1996, no antiemetics were supplied without a The Delphi technique* completed antiemetic prescription order form. The Delphi technique was adopted by the Tenon Working Group in order to reach a consensus of opinion Assessing the impact of the guidelines [8, 9] on recommendations for treating acute chemotherapyinduced nausea and vomiting. Seven oncologists, three
To assess the impact of the guidelines, a 'before and after' radiotherapists, three respiratory physicians and one study of the antiemetic drugs used in chemotherapy was hospital pharmacist constituted the group of experts.
performed at the Tenon Hospital, in 1995, 1997 and They were chosen by the Tenon Working Group because 1998, from March to August. During these three periods, they were highly qualified and experienced specialists all the consecutive in-patient units where chemotherapy working outside the Tenon Hospital.
was prescribed were enrolled in the study. Data were The 14 experts agreed to answer questions anonyentered in a Newton palm-top computer (Apple), that mously, in writing. After the first round of questions, the easily fits into a lab coat pocket. The characteristics of Tenon Working Group sent each expert a summary of this computer were as follows: 4Mb chip, 3 Mb extended the opinions expressed by the members of the Delphi life memory, and 32 bit-RISC processor. Special software group without identifying any of them. In the light of was devised in collaboration with a software development this additional information, the experts were asked to company (MdEo, Puteaux, France). Scrolling menus reiterate their opinions.
were designed by the senior clinicians constituting the This process was repeated twice (three rounds in all).
Tenon Working Group. Data on drug prescription, sex, One expert failed to answer the second round of age, and cancer sites were recorded at the patient's questions, and another did not respond at all. After the bedside. each recorded item was checked before being second and third rounds, as after the first round, the downloaded into a microcomputer in the central biostaTenon Working Group circulated the Delphi experts tistics unit. with a summary of the issues considered and the views Drug utilization was classified as 'appropriate' when expressed, and also of their comments. It was hoped that the guidelines were strictly applied. Patients were classified opinions would converge after the 3 rounds of consulas 'overtreated', either when their regimen comprised tation and that a consensus would be reached. In any higher doses than those recommended, or when a 5-HT 3 case, the Working Group agreed that the opinions antagonist was prescribed but had not been recommended. expressed in the third round would constitute the Patients were classified as 'undertreated', either when a guidelines on 5-HT3 antagonist prescription.
corticosteroid or 5-HT 3 receptor antagonist was not prescribed although it had been recommended, or when a 5-HT 3 receptor antagonist was not prescribed but had been recommended. Because prices were not stable during the study period, we based our study of cost savings on the prices prevailing in November 1998. Note guidelines obtained from the Delphi experts (Appendix 2).
The points agreed on by these experts were the considered by all the experts to be well tolerated. They were aware of the association between high doses of classification of emetogenic anticancer drugs into the three groups listed in Appendix 1, the medical indication phenothiazine and acute dyskinesia, but did not consider this a contraindication for phenothiazine administration. for each group, the list of risk factors for nausea and vomiting, a definition of the failure of antiemetic Three circumstances were considered as contraindications for the prescription of corticosteroids in cancer: treatment, and the efficacy and safety characteristics of antimetic drugs.
diabetes, gastroduodenal ulcer, and a history of psychiatric disorders. Emetogenic potential Failure of the panel of outside experts to agree on the four group classification of emetogenic anticancer drugs proposed by the Tenon Working Group Patients led to the adoption of a three group classification based on three therapeutic approaches (Appendix 1 Figure 1 shows, a rapid but transient decrease in can be used to determine the qualifications required for 5-HT 3 receptor antagonist delivery occurred between admission to further medical education in therapeutics March and August 1995. By the end of the study [10] . This technique allowed physicians to take part in courses, to improve their knowledge and also to develop prescribing skills. An appropriate organization is in place to facilitate the process. It was essential to see that the physicians who will use the guidelines take part in the process of guideline development, to ensure their co-operation and support. Accordingly, a strategy for obtaining a consensus was built into the process, and clinical experience provided part of the basis for the guidelines recommended. Furthermore, physician compliance, for instance, with the recommendations to combine corticosteroids with 5-HT 3 receptor antagonists, is easier to obtain when strong evidence of beneficial results is available. The Delphi technique enabled the experts to agree on the classification of anticancer drugs as strongly, moderately or weakly emetogenic. The pharmacological type of anticancer drugs is the most important factor in the for the application of these classifications, and there is no international agreement. This complexity lends itself to Among the factors affecting the successful introduction of guidelines based on the experts' recommendations, the use of the Delphi technique. The experts agreed on a three group classification defined above because it Grimshaw and Russel showed that the best strategy was to implement an antiemetic prescription order form [17] . corresponded to the three practical therapeutic approaches the groups had in common: (i) administration of This form is now available throughout our hospital, but its validity is limited to 1 year. Once a year, the original receptor antagonists by the i.v. route (8 mg day −1 ondansetron or 3 mg day −1 granisetron [14] ; (ii) their Delphi panel recommendations are updated by the Working Group, and the updated recommendations are administration by the oral route, and (iii) administration of non 5-HT 3 receptor antagonists. Although the efficacy validated by the group of external experts in a single round of discussions. of the combined use of corticosteroids and 5-HT 3 receptor antagonists has been established in the literature As in any uncontrolled study, which is the major limitation of the present work, it is possible that factors [15] , the results of the study carried out here before guideline implementation highlighted the local underother than those included in the guidelines defined here helped to reduce drug consumption. One effect of the prescription of corticosteroids. The Delphi group of experts agreed that it was safe for cancer patients to use drug utilization review, described elsewhere as the Hawthorne effect [7] (i.e. the beneficial effect on drug corticosteroids for short periods. Locally, the recommendations for better use of corticosteroids led to a major performance of patient inclusion in a research project) was indeed observed during the study conducted before change in therapeutic attitudes.
The Delphi process is recognized as one of the most guideline implementation. Although this effect is known to be transient, the 5-HT 3 receptor antagonist consumpvaluable ways of determining the skills required of practising physicians [16] . Furthermore, it has been shown tion measured in the study after guideline implementation remained at the lowest level ever observed in our hospital, that physicians who are willing to participate in expert panels are representative of their colleagues [17] . The 14 probably as a result of the implementation of the expert panel's recommendations. All prescriptions that do not external experts on our Delphi panel were chosen by the physicians in the Working Group of the Tenon hospital, conform to the experts' recommendations are routinely reviewed by this panel. During the drug utilization according to subjective criteria (i.e. their reputation, and their involvement in the treatment of patients with cancer review, no significant change was noted in hospital activity: thus, the number of patients admitted to the in French hospitals). Since the main objective of their recommendations for drug utilization was to provide oncology department only increased by 13% between 1996 and 1997, and decreased by 7% between 1997 and acceptable guidelines, the most important criterion was that they should be recognized as experts by the clinicians.
1998, and the duration of the hospital stay remained stable (6 days ±1). Nevertheless, we cannot assert that As the experts were asked to express their views in writing, by means of questionnaires, they did not need the conditions of the patients admitted before guideline implementation was similar to the condition observed to meet, thus minimizing the negative effects of direct group interaction. Another advantage of this process is thereafter. In addition, 5-HT 3 receptor antagonists became more popular with physicians during the study that Delphi panel members were unaware of each others' identities so no bias was introduced by conferring. The period, their efficacy was better publicised, they caused no serious adverse effects, and their cost decreased. Delphi process relies on the general expertise and experience of leading members of the professions Between 1996 and the present time (April 1999) 
